Article ID Journal Published Year Pages File Type
3336101 Transfusion and Apheresis Science 2009 5 Pages PDF
Abstract

The aim of this study was to investigate whether PMMA–CHDF in the treatment of a patient with septic acute renal failure (septic ARF) is clinically relevant. Thirteen patients were treated with PMMA–CHDF. Thirteen patients were treated with PAN–CHDF. The urinary output significantly increased in PMMA–CHDF group following 24 h of the treatment (p < 0.05), whereas those did not improve in PAN–CHDF group. The 28-day survival was 84.6% in PMMA–CHDF group and 38.5% in PAN–CHDF group, respectively (p < 0.05). We can assume that the cytokine modulation with PMMA–CHDF in the treatment of patients with septic ARF is clinically relevant.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, , , ,